Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
about
A Cost-Effectiveness Tool to Guide the Prioritization of Interventions for Rheumatic Fever and Rheumatic Heart Disease Control in African NationsImprovement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approachHealth education interventions to raise awareness of rheumatic fever: a systematic review protocol.Rheumatic fever and its management.Antibiotic prescribing for upper respiratory tract infections in the Asia-Pacific region: A brief review.Yersinia pseudotuberculosis infection in Kawasaki disease and its clinical characteristics.Antistreptolysin O titer in health and disease: levels and significanceStreptococcal pharyngitis: a prospective study of compliance and complicationsEpidemiology and prevention of valvular heart diseases and infective endocarditis in AfricaStreptococcus pyogenes and re-emergence of scarlet fever as a public health problem.Update on acute rheumatic fever: it still exists in remote communities.Congenital heart disease and rheumatic heart disease in Africa: recent advances and current prioritiesEpidemiology of heart failure in sub-Saharan Africa.Prevention and treatment of rheumatic heart disease in the developing world.Rheumatic heart disease and its control in the Pacific.Cutting edge issues in rheumatic fever.Trends in rheumatic fever: clinical aspects and perspectives in prophylactic treatments.Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease.Streptococcal pharyngitis in children: to treat or not to treat?Rheumatic Heart Disease in the Twenty-First Century.Acute rheumatic fever and rheumatic heart disease in resource-limited settings.Efficacy of a benzocaine lozenge in the treatment of uncomplicated sore throat.Treatment of streptococcal pharyngitis with once-daily amoxicillin versus intramuscular benzathine penicillin G in low-resource settings: a randomized controlled trial.Historical aspects of rheumatic fever.Incidence of acute rheumatic fever in New Zealand children and youth.The Cape Town Clinical Decision Rule for Streptococcal Pharyngitis in Children.[Diagnosis of streptococcal pharyngotonsillitis in children and adolescents: clinical picture limitations].Functional and Developmental Analysis of CD4(+)CD25(+) Regulatory T Cells under the Influence of Streptococcal M Protein in Rheumatic Heart Disease.Streptococcal pharyngitis in children with painful throat: missed opportunities for rheumatic heart disease prevention in endemic area of Africa.Echocardiographic screening for rheumatic heart disease.Rheumatic fever: neglected again.Rheumatic heart disease: infectious disease origin, chronic care approach.
P2860
Q30382040-AE47114A-1B22-4EBD-8A8B-5891121C6706Q30561289-4EA2F72B-E515-4A3C-B086-068DE8548570Q34834937-6AD05E74-3F36-483F-A6BC-D3E74E65B5F4Q35185714-EB4F3896-99D3-43D1-8ED5-56B5720B4B58Q35443148-CC0122F1-F117-4C7B-A52C-BDA5B5FDAA04Q35839567-D1C0B496-CB27-4053-88E5-D374C51D0E9AQ35977940-B2BF881E-7A29-44CE-9649-A94936AEE5E1Q36072421-927A7E19-DF92-45B0-9D1F-F4159F41B6B3Q36172985-D2C3C1C0-9EDF-4954-900D-279DD3213AC2Q36779701-BB71FB0E-159F-44C2-9547-F130924DFC35Q37192760-88A102C3-9B38-46CA-B275-497BBFEBFDA6Q37267579-2C1AAB35-8382-4231-92F5-0ECA1E4B3EC2Q37390758-044ED141-6E79-469C-BF8D-D37A7946D4FBQ37596966-25C6ECB2-C8D5-4DB4-9FCB-362F4B5F952AQ37642819-FC66F2DE-3B64-46DA-A145-846C1F02DCC0Q37877594-D93D7C3D-876D-4549-B776-125C62A75BD9Q38020883-332B2A0D-5377-4581-86D7-2F3E00CA5894Q38094958-F2CA9FCF-FF45-485A-BAB1-EC8F0105E02FQ38239054-F342B224-6913-4F75-8019-4CA0384A3022Q38377791-0C1A009E-B440-4F11-B0AE-7F2A5E0427F7Q38382463-43D5CD16-58EE-4A5E-9B42-CA5DC96D5981Q39257334-AE5437B9-E4BE-413A-85C5-404C3AE4212EQ39399351-59269172-410F-42F9-994A-93707AEFAFCAQ40173912-D7F92D20-46FA-4EAD-BFEE-F61162CBA0C5Q40290576-93994F04-C581-4547-9395-8CF1D1B19436Q40442294-0906618B-8272-4398-9808-13490A6F5D10Q41597737-8037F2C2-A8D9-481E-8E1E-DD876831E3B1Q41824924-97F4DD87-94A6-4C2A-9BF3-FA0411D922BFQ42353300-06444922-8EFE-49A6-94EB-58C174D9AC9CQ43174953-D3185D7C-BC85-4581-99CA-B24907D9869DQ45735689-E3B5FD70-BB2B-4D40-A8E1-A80AFCC2663CQ47145955-BAD388E0-980B-40B8-A3B1-55C2D4511E33
P2860
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
@ast
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
@en
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
@nl
type
label
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
@ast
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
@en
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
@nl
prefLabel
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
@ast
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
@en
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
@nl
P2860
P3181
P356
P1476
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
@en
P2093
Jimmy A Volmink
Katharine A Robertson
P2860
P2888
P3181
P356
10.1186/1471-2261-5-11
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1022097061